|
|
|
|
LEADER |
02508nmm a2200325 u 4500 |
001 |
EB000631261 |
003 |
EBX01000000000000000484343 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
140122 ||| eng |
020 |
|
|
|a 9781475729139
|
100 |
1 |
|
|a Tarter, Ralph E.
|e [editor]
|
245 |
0 |
0 |
|a Handbook of Substance Abuse
|h Elektronische Ressource
|b Neurobehavioral Pharmacology
|c edited by Ralph E. Tarter, Robert T. Ammerman, Peggy J. Ott
|
250 |
|
|
|a 1st ed. 1998
|
260 |
|
|
|a New York, NY
|b Springer US
|c 1998, 1998
|
300 |
|
|
|a XIV, 602 p
|b online resource
|
505 |
0 |
|
|a Defining Drugs of Abuse -- I. Alcohol -- 1. Pharmacology of Alcohol -- 2. Behavioral Pharmacology of Alcohol -- 3. Psychological and Psychiatric Consequences of Alcohol -- II. Caffeine -- 4. Pharmacology of Caffeine -- 5. Behavioral Pharmacology of Caffeine -- 6. Psychological and Psychiatric Consequences of Caffeine -- III. Cannabis -- 7. Pharmacology of Cannabis -- 8. Behavioral Pharmacology of Cannabinoids -- 9. Psychological and Psychiatric Consequences of Cannabis -- IV Cocaine -- 10. Pharmacology of Cocaine -- 11. Behavioral Pharmacology of Cocaine -- 12. Psychological and Psychiatric Consequences of Cocaine -- V. Hallucinogens -- 13. Pharmacology of Hallucinogens -- 14. Behavioral Pharmacology of Hallucinogens -- 15. Psychological and Psychiatric Consequences of Hallucinogens -- VI. Inhalants -- 16. Pharmacology of Inhalants -- 17. Behavioral Pharmacology of Inhalants -- 18. Psychological and Psychiatric Consequences of Inhalants -- VII. Nicotine -- 19. Pharmaco
|
653 |
|
|
|a Public health
|
653 |
|
|
|a Psychiatry
|
653 |
|
|
|a Psychiatry
|
653 |
|
|
|a Pharmacology
|
653 |
|
|
|a Public Health
|
653 |
|
|
|a Pharmacology/Toxicology
|
700 |
1 |
|
|a Ammerman, Robert T.
|e [editor]
|
700 |
1 |
|
|a Ott, Peggy J.
|e [editor]
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4757-2913-9?nosfx=y
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 615
|
520 |
|
|
|a A review of the literature pertaining to the neurobehavioral pharmacology of abusable drugs, this is the only book to survey each of the eleven classes of addictive drugs from the perspectives of neurological, behavioral, and clinical pharmacology. Designed to serve as a companion text to the DSM-IV manual, the Handbook provides comprehensive information about each drug and drug class having abuse potential with respect to their pharmaceutical mechanisms and actions
|